Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marcel H. A. Muskiet
Correction To: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults With Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
Advances in Therapy
Medicine
Pharmacology
Renal Sinus Fat and Renal Hemodynamics: A Cross-Sectional Analysis
Magnetic Resonance Materials in Physics, Biology, and Medicine
Nuclear Medicine
Radiology
Ultrasound Technology
Biophysics
Radiological
Imaging
Related publications
Insulin Glargine/Lixisenatide in Type 2 Diabetes: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics
Health Policy
Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Combination Therapy With GLP-1 Receptor Agonists and Basal Insulin: A Systematic Review of the Literature
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Fasting and Insulin Glargine in Individuals With Type 1 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Randomized, Double-Blind, Placebo-Controlled Trial of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Asian Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin With or Without a Sulfonylurea (GetGoal-L-Asia)
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes
Journal of Clinical Medicine Research